Prevalence of embolic signals in acute coronary syndromes

Stroke

Volumn 41, Issue 2, 2010, Pages 261-266

  Meseguer, Elena ^a,b   Labreuche, Julien ^a,b   Durdilly, Cloe ^b   Echeverría, Amaya ^b   Lavallee, Philippa C ^a,b   Ducrocq, Gregory ^b   Touboul, Pierre Jean ^a,b   Steg, Philippe Gabriel ^a,b   Amarenco, Pierre ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b BICHAT HOSPITAL   (France)

Author keywords

Acute coronary syndrome; Cerebrovascular event; Myocardial infarction; Stroke; Unstable angina

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOPLASTY; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; EMBOLISM; FEMALE; FIBRINOLYSIS; FOLLOW UP; HEART VALVE PROSTHESIS; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MIDDLE CEREBRAL ARTERY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; SIGNAL DETECTION; STROKE; TRANSIENT ISCHEMIC ATTACK; BRAIN EMBOLISM; COMORBIDITY; ECHOGRAPHY; FIBRINOLYTIC THERAPY; MIDDLE AGED; PATHOPHYSIOLOGY; STATISTICS; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGED; ANGINA, UNSTABLE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; COMORBIDITY; FEMALE; HUMANS; INTRACRANIAL EMBOLISM; MALE; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; PLATELET AGGREGATION INHIBITORS; PREVALENCE; THROMBOLYTIC THERAPY; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 77449142143     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.566380     Document Type: Article

References (24)

1. Witt BJ, Ballman KV, Brown RD Jr, Meverden RA, Jacobsen SJ, Roger VL. The incidence of stroke after myocardial infarction: a meta-analysis. Am J Med. 2006;119:354 e351-359.
2. Witt BJ, Brown RD Jr, Jacobsen SJ, Weston SA, Yawn BP, Roger VL. A community-based study of stroke incidence after myocardial infarction. Ann Intern Med. 2005;143:785-792.
3. Ringelstein EB, Droste DW, Babikian VL, Evans DH, Grosset DG, Kaps M, Markus HS, Russell D, Siebler M. Consensus on microembolus detection by TCD. International Consensus Group on Microembolus Detection. Stroke. 1998;29:725-729.
4. Markus HS, Thomson ND, Brown MM. Asymptomatic cérébral embolic signals in symptomatic and asymptomatic carotid artery disease. Brain. 1995;118:1005-1011.
5. Abbott AL, Levi CR, Stork JL, Donnan GA, Chambers BR. Timing of clinically significant m microembolism after carotid endarterectomy. Cerebrovasc Dis. 2007;23:362-367.
6. Abbott AL, Chambers BR, Stork JL, Levi CR, Bladin CF, Donnan GA. Embolic signals and prediction of ipsilateral stroke or transient ischemic attack in asymptomatic carotid stenosis: a multicenter prospective cohort study. Stroke. 2005;36:1128-1133.
7. Sliwka U, Georgiadis D. Clinical correlations of Doppler microembolic signals in patients with prosthetic cardiac valves: analysis of 580 cases. Stroke. 1998;29:140-143.
8. Cullinane M, Wainwright R, Brown A, Monaghan M, Markus HS. Asymptomatic embolization in subjects with atrial fibrillation not taking anticoagulants: a prospective study. Stroke. 1998;29:1810-1815.
9. Nabavi DG, Arato S, Droste DW, Schulte-Altedorneburg G, Kemeny V, Reinecke H, Borggrefe M, Breithardt G, Ringelstein EB. Microembolic load in asymptomatic patients with cardiac aneurysm, severe ventricular dysfunction, and atrial fibrillation. Clinical and hemorheological correlates. Cerebrovasc Dis. 1998;8:214-221.
10. Nadareishvili ZG, Choudary Z, Joyner C, Brodie D, Norris JW. cérébral microembolism in acute myocardial infarction. Stroke. 1999;30: 2679-2682
11. Task Force for Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of European Society of Cardiology, Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernández-Avilés F, Fox KA, Hasdai D, Ohman EM, Wallentin L, Wijns W. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J. 2007;28:1598-1660.
12. Van de Werf F, Ardissino D, Betriu A, Cokkinos DV, Falk E, Fox KA, Julian D, Lengyel M, Neumann FJ, Ruzyllo W, Thygesen C, Underwood SR, Vahanian A, Verheugt FW, Wijns W. Management of acute myo-cardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 2003;24:28-66.
13. Fox KA, Steg PG, Eagle KA, Goodman SG, Anderson FA Jr, Granger CB, Flather MD, Budaj A, Quill A, Gore JM. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA. 2007; 297:1892-1900.
14. Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Natarajan MK, Malmberg K, Rupprecht H, Zhao F, Chrolavicius S, Copland I, Fox KA. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet. 2001;358:527-533.
15. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, Jorgensen E, Marco J, Nordrehaug JE, Ruzyllo W, Urban P, Stone GW, Wijns W. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J. 2005;26:804-847.
16. Chen ZM, Jiang LX, Chen YP, Xie JX, Pan HC, Peto R, Collins R, Liu LS. Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet. 2005; 366:1607-1621.
17. Sabatine MS, Cannon CP, Gibson CM, Lopez-Sendon JL, Montalescot G, Theroux P, Claeys MJ, Cools F, Hill KA, Skene AM, McCabe CH, Braunwald E. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med. 2005;352:1179-1189. (Pubitemid 40397259)
18. Markus HS, Droste DW, Kaps M, Larrue V, Lees KR, Siebler M, Ringelstein EB. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection: the Clo-pidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation. 2005;111:2233-2240.
19. Junghans U, Siebler M. cérébral microembolism is blocked by tirofiban, a selective nonpeptide platelet glycoprotein IIb/IIIa receptor antagonist. Circulation. 2003;107:2717-2721.
20. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361:13-20.
21. Eagle KA, Nallamothu BK, Mehta RH, Granger CB, Steg PG, Van de Werf F, López-Sendón J, Goodman SG, Quill A, Fox KA. Global Registry of Acute Coronary Events (GRACE) Investigators. Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go. Eur Heart J. 2008;29:609-617.
22. Johannessen KA, Nordrehaug JE, von der Lippe G, Vollset SE. Risk factors for embolisation in patients with left ventricular thrombi and acute myocardial infarction. Br Heart J. 1988;60:104-110.
23. Loh E, Sutton MS, Wun CC, Rouleau JL, Flaker GC, Gottlieb SS, Lamas GA, Moye LA, Goldhaber SZ, Pfeffer MA. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med. 1997;336: 251-257.
24. Spence JD, Coates V, Li H, Tamayo A, Munoz C, Hackam DG, DiCicco M, DesRoches J, Bogiatzi C, Klein J, Madrenas J, Hegele RA. Effects of intensive medical therapy, on microemboli and cardiovascular risk in asymptomatic carotid stenosis. Arch Neurol. Epub ahead of print.